Advanced search
Publication Cover
Expert Opinion on Therapeutic Targets Volume 11, 2007 - Issue 10
Submit an article Journal homepage
204
Views
28
CrossRef citations to date
0
Altmetric
Review

c-Jun N-terminal kinases as potential therapeutic targets

Baljinder Salh Associate Professor, University of British Columbia, Department of Medicine, Vancouver, BC, Canada; Jack Bell Research Center, 2660 Oak Street, Vancouver, BC, V6H 3Z6, Canada; Division of Gastroenterology, 5153-2775 Laurel Street, Vancouver, BC, V5Z 1M9, Canada + 1 604 875 5287; + 1 604 875 5447; [email protected]
, FRCPC
Pages 1339-1353 | Published online: 02 Oct 2007

Bibliography

  • LANDER ES, LINTON LM, BIRREN B et al.: Initial sequencing and analysis of the human genome. Nature (2001) 409(6822):860-921.
  • SCHLESSINGER J: Cell signaling by receptor tyrosine kinases. Cell (2000) 103(2):211-225.
  • MEDZHITOV R: Toll-like receptors and innate immunity. Nat. Rev. Immunol. (2001) 1(2):135-145.
  • SIEGEL PM, MASSAGUE J: Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer. Nat. Rev. Cancer (2003) 3(11):807-821.
  • BARDWELL L, COOK JG, INOUYE CJ, THORNER J: Signal propagation and regulation in the mating pheromone response pathway of the yeast Saccharomyces cerevisiae. Dev. Biol. (1994) 166(2):363-379.
  • KYRIAKIS JM, AVRUCH J: pp54 microtubule-associated protein 2 kinase. A novel serine/threonine protein kinase regulated by phosphorylation and stimulated by poly-L-lysine. J. Biol. Chem. (1990) 265(28):17355-17363.
  • DAVIS RJ: Signal transduction by the JNK group of MAP kinases. Cell (2000) 103(2):239-252.
  • GUPTA S, BARRETT T, WHITMARSH AJ et al.: Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J. (1996) 15(11):2760-2770.
  • LANG R, HAMMER M, MAGES J: DUSP meet immunology: dual specificity MAPK phosphatases in control of the inflammatory response. J. Immunol. (2006) 177(11):7497-7504.
  • ORTH K, PALMER LE, BAO ZQ et al.: Inhibition of the mitogen-activated protein kinase kinase superfamily by a Yersinia effector. Science (1999) 285(5435):1920-1923.
  • DUESBERY NS, WEBB CP, LEPPLA SH et al.: Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science (1998) 280(5364):734-737.
  • WAN YY, CHI H, XIE M, SCHNEIDER MD, FLAVELL RA: The kinase TAK1 integrates antigen and cytokine receptor signaling for T cell development, survival and function. Nat. Immunol. (2006) 7(8):851-858.
  • SATO S, SANJO H, TAKEDA K et al.: Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat. Immunol. (2005) 6(11):1087-1095.
  • WHITMARSH AJ, DAVIS RJ: Structural organization of MAP-kinase signaling modules by scaffold proteins in yeast and mammals. Trends Biochem. Sci. (1998) 23(12):481-485.
  • WAETZIG V, HERDEGEN T: Context-specific inhibition of JNKs: overcoming the dilemma of protection and damage. Trends Pharmacol. Sci. (2005) 26(9):455-461.
  • VENTURA JJ, KENNEDY NJ, LAMB JA, FLAVELL RA, DAVIS RJ: c-Jun NH(2)-terminal kinase is essential for the regulation of AP-1 by TNF. Mol. Cell Biol. (2003) 23(8):2871-2882.
  • EFERL R, WAGNER EF: AP-1: a double-edged sword in tumorigenesis. Nat. Rev. Cancer (2003) 3(11):859-868.
  • ABRAHAM SM, LAWRENCE T, KLEIMAN A et al.: Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1. J. Exp. Med. (2006) 203(8):1883-1889.
  • SWANTEK JL, COBB MH, GEPPERT TD: Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor α (TNF-α) translation: glucocorticoids inhibit TNF-α translation by blocking JNK/SAPK. Mol. Cell Biol. (1997) 17(11):6274-6282.
  • DONG C, DAVIS RJ, FLAVELL RA: MAP kinases in the immune response. Annu. Rev. Immunol. (2002) 20:55-72.
  • ARBOUR N, NANICHE D, HOMANN D et al.: c-Jun NH(2)-terminal kinase (JNK)1 and JNK2 signaling pathways have divergent roles in CD8(+) T cell-mediated antiviral immunity. J. Exp. Med. (2002) 195(7):801-810.
  • CONZE D, KRAHL T, KENNEDY N et al.: c-Jun NH(2)-terminal kinase (JNK)1 and JNK2 have distinct roles in CD8(+) T cell activation. J. Exp. Med. (2002) 195(7):811-823.
  • BLONSKA M, PAPPU BP, MATSUMOTO R et al.: The CARMA1-Bcl10 signaling complex selectively regulates JNK2 kinase in the T cell receptor-signaling pathway. Immunity (2007) 26(1):55-66.
  • HAN Z, BOYLE DL, CHANG L et al.: c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J. Clin. Invest. (2001) 108(1):73-81.
  • HAN Z, CHANG L, YAMANISHI Y, KARIN M, FIRESTEIN GS: Joint damage and inflammation in c-Jun N-terminal kinase 2 knockout mice with passive murine collagen-induced arthritis. Arthritis Rheum. (2002) 46(3):818-823.
  • SVENSSON CI, ZATTONI M, SERHAN CN: Lipoxins and aspirin-triggered lipoxin inhibit inflammatory pain processing. J. Exp. Med. (2007) 204(2):245-252.
  • DAULHAC L, MALLET C, COURTEIX C et al.: Diabetes-induced mechanical hyperalgesia involves spinal mitogen-activated protein kinase activation in neurons and microglia via N-methyl-D-aspartate-dependent mechanisms. Mol. Pharmacol. (2006) 70(4):1246-1254.
  • HOLLOWAY G, COULSON BS: Rotavirus activates JNK and p38 signaling pathways in intestinal cells, leading to AP-1-driven transcriptional responses and enhanced virus replication. J. Virol. (2006) 80(21):10624-10633.
  • BECKHAM JD, GOODY RJ, CLARKE P, BONNY C, TYLER KL: A novel strategy for the treatment of viral CNS infection utilizing a cell-permeable inhibitor of c-Jun N-terminal kinase. J. Virol. (2007).
  • LU Z, SERGHIDES L, PATEL SN et al.: Disruption of JNK2 decreases the cytokine response to Plasmodium falciparum glycosylphosphatidylinositol in vitro and confers protection in a cerebral malaria model. J. Immunol. (2006) 177(9):6344-6352.
  • KENZEL S, MANCUSO G, MALLEY R et al.: c-Jun kinase is a critical signaling molecule in a neonatal model of group B streptococcal sepsis. J. Immunol. (2006) 176(5):3181-3188.
  • BEHRENS A, JOCHUM W, SIBILIA M, WAGNER EF: Oncogenic transformation by ras and fos is mediated by c-Jun N-terminal phosphorylation. Oncogene (2000) 19(22):2657-2663.
  • KENNEDY NJ, DAVIS RJ: Role of JNK in tumor development. Cell Cycle (2003) 2(3):199-201.
  • NIELSEN C, THASTRUP J, BOTTZAUW T, JAATTELA M, KALLUNKI T: c-Jun NH2-terminal kinase 2 is required for Ras transformation independently of activator protein 1. Cancer Res. (2007) 67(1):178-185.
  • TENG DH, PERRY WL III, HOGAN JK et al.: Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor. Cancer Res. (1997) 57(19):4177-4182.
  • YAMAGATA H, MATSUZAKI K, MORI S et al.: Acceleration of Smad2 and Smad3 phosphorylation via c-Jun NH(2)-terminal kinase during human colorectal carcinogenesis. Cancer Res. (2005) 65(1):157-165.
  • SHINTANI Y, WHEELOCK MJ, JOHNSON KR: Phosphoinositide-3 kinase-Rac1-c-Jun NH2-terminal kinase signaling mediates collagen I-induced cell scattering and up-regulation of N-cadherin expression in mouse mammary epithelial cells. Mol. Biol. Cell (2006) 17(7):2963-2975.
  • SHINTANI Y, HOLLINGSWORTH MA, WHEELOCK MJ, JOHNSON KR: Collagen I promotes metastasis in pancreatic cancer by activating c-Jun NH(2)-terminal kinase 1 and up-regulating N-cadherin expression. Cancer Res. (2006) 66(24):11745-11753.
  • KIM SJ, ANGEL P, LAFYATIS R et al.: Autoinduction of transforming growth factor β1 is mediated by the AP-1 complex. Mol. Cell Biol. (1990) 10(4):1492-1497.
  • VENTURA JJ, KENNEDY NJ, FLAVELL RA, DAVIS RJ: JNK regulates autocrine expression of TGF-β1. Mol. Cell (2004) 15(2):269-278.
  • VEEMAN MT, AXELROD JD, MOON RT: A second canon. Functions and mechanisms of β-catenin-independent Wnt signaling. Dev. Cell (2003) 5(3):367-377.
  • NATERI AS, SPENCER-DENE B, BEHRENS A: Interaction of phosphorylated c-Jun with TCF4 regulates intestinal cancer development. Nature (2005) 437(7056):281-285.
  • KHATLANI TS, WISLEZ M, SUN M et al.: c-Jun N-terminal kinase is activated in non-small-cell lung cancer and promotes neoplastic transformation in human bronchial epithelial cells. Oncogene (2007) 26(18):2658-2666.
  • CUI J, HAN SY, WANG C et al.: c-Jun NH(2)-terminal kinase 2α2 promotes the tumorigenicity of human glioblastoma cells. Cancer Res. (2006) 66(20):10024-10031.
  • YANG DD, KUAN CY, WHITMARSH AJ et al.: Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature (1997) 389(6653):865-870.
  • TOURNIER C, HESS P, YANG DD et al.: Requirement of JNK for stress-induced activation of the cytochrome C-mediated death pathway. Science (2000) 288(5467):870-874.
  • LEI K, DAVIS RJ: JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis. Proc. Natl. Acad. Sci. USA (2003) 100(5):2432-2437.
  • TSURUTA F, SUNAYAMA J, MORI Y et al.: JNK promotes Bax translocation to mitochondria through phosphorylation of 14-3-3 proteins. EMBO J. (2004) 23(8):1889-1899.
  • MICHEAU O, TSCHOPP J: Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell (2003) 114(2):181-190.
  • DE SMAELE E, ZAZZERONI F, PAPA S et al.: Induction of gadd45β by NF-κB downregulates pro-apoptotic JNK signalling. Nature (2001) 414(6861):308-313.
  • TANG G, MINEMOTO Y, DIBLING B et al.: Inhibition of JNK activation through NF-κB target genes. Nature (2001) 414(6861):313-317.
  • LEE EG, BOONE DL, CHAI S et al.: Failure to regulate TNF-induced NF-κB and cell death responses in A20-deficient mice. Science (2000) 289(5488):2350-2354.
  • THANNICKAL VJ, FANBURG BL: Reactive oxygen species in cell signaling. Am. J. Physiol. Lung Cell Mol. Physiol. (2000) 279(6):L1005-L1028.
  • SAKON S, XUE X, TAKEKAWA M et al.: NF-κB inhibits TNF-induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death. EMBO J. (2003) 22(15):3898-3909.
  • COLELL A, GARCIA-RUIZ C, MIRANDA M et al.: Selective glutathione depletion of mitochondria by ethanol sensitizes hepatocytes to TNF. Gastroenterology (1998) 115(6):1541-1551.
  • PHAM CG, BUBICI C, ZAZZERONI F et al.: Ferritin heavy chain upregulation by NF-κB inhibits TNFα-induced apoptosis by suppressing reactive oxygen species. Cell (2004) 119(4):529-542.
  • SAITOH M, NISHITOH H, FUJII M et al.: Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. (1998) 17(9):2596-2606.
  • TOBIUME K, MATSUZAWA A, TAKAHASHI T et al.: ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep. (2001) 2(3):222-228.
  • KAMATA H, HONDA S, MAEDA S et al.: Reactive oxygen species promote TNFα-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell (2005) 120(5):649-661.
  • CHANG L, KAMATA H, SOLINAS G et al.: The E3 ubiquitin ligase itch couples JNK activation to TNFα-induced cell death by inducing c-FLIP(L) turnover. Cell (2006) 124(3):601-613.
  • NAKAJIMA A, KOMAZAWA-SAKON S, TAKEKAWA M et al.: An antiapoptotic protein, c-FLIPL, directly binds to MKK7 and inhibits the JNK pathway. EMBO J. (2006) 25(23):5549-5559.
  • WULLAERT A, HEYNINCK K, BEYAERT R: Mechanisms of crosstalk between TNF-induced NF-κB and JNK activation in hepatocytes. Biochem. Pharmacol. (2006) 72(9):1090-1101.
  • VENTURA JJ, HUBNER A, ZHANG C et al.: Chemical genetic analysis of the time course of signal transduction by JNK. Mol. Cell (2006) 21(5):701-710.
  • SABAPATHY K, JOCHUM W, HOCHEDLINGER K et al.: Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2. Mech. Dev. (1999) 89(1-2):115-124.
  • ALMEIDA EA, ILIC D, HAN Q et al.: Matrix survival signaling: from fibronectin via focal adhesion kinase to c-Jun NH(2)-terminal kinase. J. Cell Biol. (2000) 149(3):741-754.
  • WANG MC, BOHMANN D, JASPER H: JNK extends life span and limits growth by antagonizing cellular and organism-wide responses to insulin signaling. Cell (2005) 121(1):115-125.
  • OH SW, MUKHOPADHYAY A, SVRZIKAPA N et al.: JNK regulates lifespan in Caenorhabditis elegans by modulating nuclear translocation of forkhead transcription factor/DAF-16. Proc. Natl. Acad. Sci. USA (2005) 102(12):4494-4499.
  • BERNSTEIN CN, WAJDA A, SVENSON LW et al.: The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am. J. Gastroenterol. (2006) 101(7):1559-1568.
  • BOUMA G, STROBER W: The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. (2003) 3(7):521-533.
  • HOMMES D, VAN DEN BLINK B, PLASSE T et al.: Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease. Gastroenterology (2002) 122(1):7-14.
  • WAETZIG GH, SEEGERT D, ROSENSTIEL P, NIKOLAUS S, SCHREIBER S: p38 Mitogen-activated protein kinase is activated and linked to TNF-α signaling in inflammatory bowel disease. J. Immunol. (2002) 168(10):5342-5351.
  • BANTEL H, SCHMITZ ML, RAIBLE A, GREGOR M, SCHULZE-OSTHOFF K: Critical role of NF-κB and stress-activated protein kinases in steroid unresponsiveness. FASEB J. (2002) 16(13):1832-1834.
  • ASSI K, PILLAI R, GOMEZ-MUNOZ A, OWEN D, SALH B: The specific JNK inhibitor SP600125 targets TNF-α production and epithelial cell apoptosis in acute murine colitis. Immunology (2006) 118(1):112-121.
  • MATSUMARU K, JI C, KAPLOWITZ N: Mechanisms for sensitization to TNF-induced apoptosis by acute glutathione depletion in murine hepatocytes. Hepatology (2003) 37(6):1425-1434.
  • GUNAWAN BK, LIU ZX, HAN D et al.: c-Jun N-terminal kinase plays a major role in murine acetaminophen hepatotoxicity. Gastroenterology (2006) 131(1):165-178.
  • SCHATTENBERG JM, SINGH R, WANG Y et al.: JNK1 but not JNK2 promotes the development of steatohepatitis in mice. Hepatology (2006) 43(1):163-172.
  • THORGEIRSSON SS, GRISHAM JW: Molecular pathogenesis of human hepatocellular carcinoma. Nat. Genet. (2002) 31(4):339-346.
  • MAEDA S, CHANG L, LI ZW et al.: IKKβ is required for prevention of apoptosis mediated by cell-bound but not by circulating TNFα. Immunity (2003) 19(5):725-737.
  • SAKURAI T, MAEDA S, CHANG L, KARIN M: Loss of hepatic NF-κB activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation. Proc. Natl. Acad. Sci. USA (2006) 103(28):10544-10551.
  • BOGOYEVITCH MA: The isoform-specific functions of the c-Jun N-terminal kinases (JNKs): differences revealed by gene targeting. Bioessays (2006) 28(9):923-934.
  • HERDEGEN T, CLARET FX, KALLUNKI T et al.: Lasting N-terminal phosphorylation of c-Jun and activation of c-Jun N-terminal kinases after neuronal injury. J. Neurosci. (1998) 18(14):5124-5135.
  • BORSELLO T, CLARKE PG, HIRT L et al.: A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia. Nat. Med. (2003) 9(9):1180-1186.
  • KUAN CY, WHITMARSH AJ, YANG DD et al.: A critical role of neural-specific JNK3 for ischemic apoptosis. Proc. Natl. Acad. Sci. USA (2003) 100(25):15184-5189.
  • HUNOT S, VILA M, TEISMANN P et al.: JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease. Proc. Natl. Acad. Sci. USA (2004) 101(2):665-670.
  • WILHELM M, XU Z, KUKEKOV NV, GIRE S, GREENE LA: Proapoptotic Nix activates the JNK pathway by interacting with POSH and mediates death in a Parkinson disease model. J. Biol. Chem. (2007) 282(2):1288-1295.
  • MORISHIMA Y, GOTOH Y, ZIEG J et al.: β-Amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand. J. Neurosci. (2001) 21(19):7551-7560.
  • MANNING AM, DAVIS RJ: Targeting JNK for therapeutic benefit: from junk to gold? Nat. Rev. Drug Discov. (2003) 2(7):554-565.
  • TRAN EH, AZUMA YT, CHEN M et al.: Inactivation of JNK1 enhances innate IL-10 production and dampens autoimmune inflammation in the brain. Proc. Natl. Acad. Sci. USA (2006) 103(36):13451-13456.
  • RICCI R, SUMARA G, SUMARA I et al.: Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis. Science (2004) 306(5701):1558-1561.
  • KAISER RA, LIANG Q, BUENO O et al.: Genetic inhibition or activation of JNK1/2 protects the myocardium from ischemia-reperfusion-induced cell death in vivo. J. Biol. Chem. (2005) 280(38):32602-32608.
  • YOSHIMURA K, AOKI H, IKEDA Y et al.: Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase. Nat. Med. (2005) 11(12):1330-1338.
  • HOTAMISLIGIL GS: Inflammation and metabolic disorders. Nature (2006) 444(7121):860-867.
  • HIROSUMI J, TUNCMAN G, CHANG L et al.: A central role for JNK in obesity and insulin resistance. Nature (2002) 420(6913):333-336.
  • TUNCMAN G, HIROSUMI J, SOLINAS G et al.: Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance. Proc. Natl. Acad. Sci. USA (2006) 103(28):10741-10746.
  • HOTAMISLIGIL GS: Role of endoplasmic reticulum stress and c-Jun NH2-terminal kinase pathways in inflammation and origin of obesity and diabetes. Diabetes (2005) 54(Suppl. 2):S73-S78.
  • WANG XM, ZHANG Y, KIM HP et al.: Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis. J. Exp. Med. (2006) 203(13):2895-2906.
  • BENNETT BL: c-Jun N-terminal kinase-dependent mechanisms in respiratory disease. Eur. Respir. J. (2006) 28(3):651-661.
  • ZHAO H, SERBY MD, XIN Z et al.: Discovery of potent, highly selective, and orally bioavailable pyridine carboxamide c-Jun NH2-terminal kinase inhibitors. J. Med. Chem. (2006) 49(15):4455-4458.
  • AGGARWAL BB, KUMAR A, BHARTI AC: Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. (2003) 23(1A):363-398.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.